Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v5-FR
Language English French
Date Updated 2025-11-27 2025-08-08
Drug Identification Number 02443279 02443279
Brand name NXSTAGE PUREFLOW SOLUTION RFP-204-CAN NXSTAGE PUREFLOW SOLUTION RFP-204-CAN
Common or Proper name Hemodialysis Solution Hemodialysis Solution
Company Name NXSTAGE MEDICAL INC NXSTAGE MEDICAL INC
Ingredients DEXTROSE SODIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM LACTATE DEXTROSE SODIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM LACTATE
Strength(s) 1.1G 5.844G 0.221G 0.075G 0.102G 7.473G 1.1G 5.844G 0.221G 0.075G 0.102G 7.473G
Dosage form(s) SOLUTION SOLUTION
Route of administration HAEMODIALYSIS DIALYSIS HAEMODIALYSIS DIALYSIS
Packaging size 5000 mL per bag/ Two (2) bags per shipping carton 5000 mL per bag/ Two (2) bags per shipping carton
ATC code B05Z B05Z
ATC description HEMODIALYTICS AND HEMOFILTRATES HEMODIALYTICS AND HEMOFILTRATES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2025-10-31 2025-10-31
Actual start date 2025-11-26
Estimated end date 2026-03-30 2025-11-27
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments